Transitional Assistance. Sellers shall reasonably cooperate with and assist Questron in the orderly transfer of the business of the Company after the Closing Date. Such cooperation and assistance shall include, but not be limited to, the physical transfer of any books, records and computer software of the Company.
Transitional Assistance. 29 5.8 Conditions....................................................29 5.9 Rule 144......................................................29 5.10
Transitional Assistance. If the Company shall so request, Executive shall provide reasonable assistance to the Company to help ensure an orderly transition of Executive's duties and responsibilities to such individual(s) as the Company may designate, provided that the period during which Executive shall provide such assistance shall not exceed ninety (90) days and that during such period Executive's employment with the Company shall continue and the Company shall compensate Executive as described in Section 2(b) above. Any such transitional assistance and continuation of employment shall not waive, release or otherwise affect any of the Executive's rights or the Company's obligations hereunder, including without limitation those set forth in Section 4 below.
Transitional Assistance. The conference agreement provides special provisions for low-income persons. A transitional assistance eligible individual will be entitled to have his or her discount card enrollment fee paid. Those individuals with incomes below 100% of poverty (special transitional assistance eligible individuals) would be liable for coinsurance charges of 5% of incurred costs up to $600 in both 2004 and 2005. Other transitional assistance eligible individuals (those with incomes between 100% and 135% of poverty) would be liable for coinsurance charges of 10 % of incurred costs up to $600 in both 2004 and 2005. Thus, the program will pay 95% of a special transitional eligible individual’s incurred drug costs up to $600 in 2004 and 90% of other transitional eligible individual’s incurred drug costs up to $600 in 2004. Similarly, payment would be made for 95% or 90%, whichever is appropriate, of the individual’s incurred drug costs up to $600 in 2005. In addition, any balance left over from 2004 may be added to the amount available in 2005, except no rollover would be permitted if the individual voluntarily disenrolled from an endorsed plan. No funds will be available under this program for covered discount card drugs dispensed after December 31, 2005. The Secretary will provide a method for the reimbursement of card sponsors for transitional assistance. The $600 annual amount is to be prorated in 2004, for persons not enrolling in an endorsed program and providing self-certification prior to the program’s initial implementation date. For 2005, the amount is to be prorated for persons not enrolling in an endorsed program and providing self-certification prior to February 1, 2005. The conference agreement permits a pharmacy to reduce the coinsurance otherwise applicable. It also permits states to pay some or all of the coinsurance for some or all transitional assistance eligible enrollees. The payment would be made directly by the state to the pharmacy. No federal matching payments would be available for these costs; further they could not be considered as Medicare cost-sharing for purposes of the qualified Medicare beneficiary program. The conference agreement includes provisions to ensure access to transitional assistance for qualified residents of long-tem care facilities and American Indians. It requires the Secretary to establish procedures to ensure such access for qualified residents of long-term care facilities. The Secretary could waive requirements of the new Sec...
Transitional Assistance. Seller, for a period of 120 days after the Closing Date, shall, at Purchaser’s sole cost and expense, provide to Purchaser reasonable transitional assistance in connection with its sale of the Product in the Territory; provided, however, (i) notwithstanding anything set forth in Section 9.14(b), any costs in connection with the transfer of any NDA or Marketing Authorization Application to Purchaser shall be Seller’s sole cost and expense, and (ii) nothing contained herein shall require Seller to maintain any level of commercial infrastructure or expertise (other than regulatory) post-Closing to support Purchaser, including without limitation with respect to maintenance of field support, employees, promotional activities or managed care activities.
Transitional Assistance. During the severance period while Executive is receiving severance payments from the Company, or for ninety (90) days following a voluntary termination by Executive of his employment without Good Reason, Executive agrees to provide the Company with any reasonable assistance requested by the Company without the necessity of any additional payment to Executive other than payment of Executive’s reasonable out-of-pocket expenses.
Transitional Assistance. The Company and the Shareholders shall reasonably cooperate with and assist QDL in the orderly transfer of the Business of the Company after the Closing Date. Such cooperation and assistance shall include, but not be limited to, the physical transfer of any Books and Records and computer software of the Company.
Transitional Assistance. 12.1 In the event of the termination for any reason of the Services by LGSS, LGSS shall provide Transitional Assistance to the Administering Authority.
Transitional Assistance. 39.1At any time in the period of 6 (six) months leading up to the expiry or termination of this agreement (for whatever reason), the Provider shall provide such information and assistance as the Authority may reasonably request in connection with any aspect of the provision of the Services by the Provider.
Transitional Assistance. During the term of this Agreement, Aradigm will use commercially reasonable efforts to provide to Novo Nordisk Delivery Technologies, Inc. and its Affiliates, at Novo Nordisk Delivery Technologies, Inc.’s expense, consultation, assistance and information as reasonably requested by them, and will otherwise perform the Services, so as to effect a smooth transition from Novo Nordisk Delivery Technologies, Inc.’s utilization of the Services to Novo Nordisk Delivery Technologies, Inc.’s utilization of its own systems and personnel in connection with the Development Program prior to the termination or expiration of this Agreement.
